EPH Receptor A6 anticorps (Extracellular, N-Term)
Aperçu rapide pour EPH Receptor A6 anticorps (Extracellular, N-Term) (ABIN7884939)
Antigène
Voir toutes EPH Receptor A6 (Epha6) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Épitope
- AA 482-495, Extracellular, N-Term
-
Fonction
- A Rabbit Polyclonal Antibody to EphA6 Receptor
-
Homologie
- Mouse,human - identical
-
Purification
- Affinity purified on immobilized antigen.
-
Immunogène
- (C)KEHEQLTYSSTRSK, corresponding to amino acid residues 482-495 of rat EphA6
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB: 1:200-1:400
FC: 2.5 μg per reaction
ICC: The optimal concentration should be determined by the user
IHC: 1:200
IP: The optimal concentration should be determined by the user
-
Commentaires
-
Negative Control: (ABIN7235290)
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 0.2 mL double distilled water (DDW)
-
Concentration
- 1 mg/mL
-
Buffer
- PBS pH 7.4
-
Agent conservateur
- Without preservative
-
Stock
- -20 °C
-
Stockage commentaire
- The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
-
-
- EPH Receptor A6 (Epha6)
-
Autre désignation
- Ephrin type-A receptor 6
-
Sujet
-
Synonyms: Ephrin type-A receptor 6, EPH receptor A6, EPH homology kinase 2, EHK-2
Description: EphA6 is an erythropoietin-producing hepatocellular (Eph) receptor that belongs to the tyrosine kinase receptor family. The Eph receptor family consists of 9 EphA receptors and 5 EphB receptors, which serve key roles in normal physiology, including cell migration, cell adhesion, cell proliferation and neuronal synaptic plasticity. These activities depend on the binding of their Eph receptor-interacting (ephrin) proteins, of which include 8 members. Compelling data has demonstrated that Eph receptors and ephrins affect tumor growth, invasiveness, angiogenesis and metastasis1. They are also involved in brain development, learning and memory2.EphA6 signaling pathways are inhibitory for developing axons and blocking these pathways enhances regeneration following spinal cord and brain injury, rendering EphA6 an appealing drug target3.Eph receptors contain an extracellular structure consisting of an ephrin binding domain, the juxtamembrane region connects the extracellular portion of the receptor to the intracellular kinase domain. Two Tyrosine residues on the juxtamembrane region mediate autophosphorylation and receptor dimerization mediates the formation of heterocomplexes that are required for signaling4.
-
ID gène
- 29202
-
UniProt
- P54758
-
Pathways
- Signalisation RTK
Antigène
-